Does Smoking Make You Look Older
Research shows smokers more susceptible to non-melanoma skin cancers, wrinkles, skin aging, psoriasis, dental problems and hair loss (Source: Disabled World)
Source: Disabled World - July 20, 2016 Category: Disability Tags: Dermatology Source Type: news

15, 30, 50, 70... Which SPF Should I Use?
By GalTime.com Seems like you need a PhD in SPF these days to understand what's on the label of most sunscreens. And believe you me, you want to make sure you have the right sunscreen slathered on your body before you hit the beach! Non-melanoma skin cancer is now the most common type of cancer in America. More than 3.5 million cases are reported annually... and that's just the reported cases. Many patients are treated in the doctor's office and a good number of those aren't included in the count. That's why the Archives of Dermatology recently called non-melanoma skin cancer an "under-recognized epidemic" in t...
Source: Healthy Living - The Huffington Post - July 19, 2016 Category: Consumer Health News Source Type: news

Many skin cancer patients still too likely to sunburn
A recent study concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 19, 2016 Category: Science Source Type: news

Many skin cancer patients still too likely to sunburn
(Johns Hopkins Medicine) A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2016 Category: Cancer & Oncology Source Type: news

'Secret ginger gene' may increase skin cancer risk for millions
Conclusion The study adds more weight to the importance of using sun protection to avoid skin cancer. We already know that people with red hair and freckles who burn easily are at increased risk of skin cancer. This study suggests other people may also have a higher risk, without knowing it. Taking sensible sun protection measures makes good sense for everyone. The findings are also useful for researchers, as they add to our understanding about how certain genetic traits affect the development of skin cancer. If DNA repair is reduced in people with some gene variants, sun damage may not be the only thing affecting th...
Source: NHS News Feed - July 13, 2016 Category: Consumer Health News Tags: Cancer Genetics/stem cells Source Type: news

Everything You Need To Know About Choosing The Best Sunscreen
Fourth of July weekend is upon us, and along with barbecue equipment, beach toys and sandals, don't forget to stock up on some sunscreen for the holiday. Sun damage is responsible for 90 percent of nonmelanoma skin cancers in the United States, itself the most common form of cancer in the country, according to the Skin Cancer Foundation. In fact, more than 3.3 million people are diagnosed with skin cancer in the U.S. each year. The Food and Drug Administration recommends that consumers look for three things in their sunscreen: a "sun protection factor" (SPF) of 15 or more, "broad spectrum" protec...
Source: Healthy Living - The Huffington Post - July 1, 2016 Category: Consumer Health News Source Type: news

Sensus Healthcare closes $11m IPO
Sensus Healthcare (NSDQ:SRTSU) said today it closed its initial public offering, raising $11 million through the sale of 2.3 million units at $5.50 each. The offering included a fully-exercised underwriters option of an additional 300,000 units at the IPO price, Sensus said. Each share consists of a unit of stock and a 3-year warrant with an exercise price of $6.75. The offering units are slated to split by July 25, with the stock shares trading on the NASDAQ exchange under the “SRTS” symbol and the warrants under the “SRTSW” symbol. Sensus makes low-energy photon X-ray systems for treating non...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Funding Roundup Initial Public Offering (IPO) Radiosurgery Sensus Healthcare LLC Source Type: news

Sensus Healthcare prices $11m IPO
Sensus Healthcare (NSDQ:SRTSU) priced an $11 million initial public offering yesterday, saying it plans to float 2 million shares at $5.50 apiece starting today. Boca Raton, Fla.-based Sensus said the offering, expected to close June 8, also includes a 300,000-unit over-allotment option for the IPO’s underwriters. Each share consists of a unit of stock and a 3-year warrant with an exercise price of $6.75. The offering units are slated to split by July 25, with the stock shares trading on the NASDAQ exchange under the “SRTS” symbol and the warrants under the “SRTSW” symbol. Sensus mak...
Source: Mass Device - June 3, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Radiosurgery Wall Street Beat Sensus Healthcare LLC Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Otsuka gets in on ReCor Medical’s Paradise renal denervation device ReCor Medical said it landed a strategic investment from Japanese conglomerate Otsuka Pharmaceutical that will bring to Asia its Paradise renal denervati...
Source: Mass Device - May 16, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Plus 5 Source Type: news

Sensus Healthcare scales back planned IPO
Sensus Healthcare last week said it plans to scale back its planned initial public offering, after tabling the flotation earlier this year. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas. The company said March 9 that it planned to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. Later that month, Sensus postponed the IPO. But in a May 13 regulatory fi...
Source: Mass Device - May 16, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Oncology Radiosurgery Sensus Healthcare LLC Source Type: news

Search is on for cases of aggressive, ruxolitinib-associated skin cancers
ORLANDO – The hematologic cancer drug ruxolitinib seems to be associated with cases of aggressive nonmelanoma skin cancer. After treating a very aggressive squamous cell carcinoma in a 55-year-old man treated with ruxolitinib for polycythemia vera, and hearing firsthand of three other similar... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 30, 2016 Category: Dermatology Source Type: news

Sensus Healthcare postpones IPO
Sensus Healthcare reportedly postponed its initial public offering today, after setting terms earlier this month with a midpoint raise of $20 million. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas. The company said March 9 that it planned to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. A mere 8 IPOs have priced in 2016, all in the health...
Source: Mass Device - March 30, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Dermatology Sensus Healthcare LLC Source Type: news

Online skin cancer risk assessment tool can predict non-melanoma skin cancer
A new online tool allows people to assess their risks of developing skin cancer in the next three years. Aimed at people over 40, the tool determines the risk level in only a few questions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2016 Category: Consumer Health News Source Type: news

Sensus Healthcare sets terms on $20m IPO
Sensus Healthcare yesterday set the terms on an initial public offering that would raise $20 million at the mid-point. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma. Sensus said it plans to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. Sensus said it’s won 510(k) clearance from the FDA, CE Mark approval in the European Union and nods from the China Food...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Radiosurgery Sensus Healthcare LLC Source Type: news

New NICE guidelines on sun exposure warn 'tanning is unsafe'
"No safe way to suntan, new NICE guidance warns," BBC News reports. The guidelines, produced by the National Institute for Health and Care Excellence (NICE), also stresses the benefits of moderate sun exposure. This will help prevent vitamin D deficiency; which is more common in the UK than many people realise. It is estimated that around one in five adults and older children (aged between 11 and 18) have low vitamin D status. The figure is around one in seven for younger children.   What are the risks of overexposure? Sunlight contains ultraviolet A (UVA) and ultraviolet B (UVB) radiation, both of whi...
Source: NHS News Feed - February 10, 2016 Category: Consumer Health News Tags: Lifestyle/exercise Cancer QA articles Source Type: news

Average person with atopic dermatitis has no increased risk of actinic keratosis or nonmelanoma skin cancer
People with atopic dermatitis do not appear to be at greater risk for actinic keratosis or basal cell and squamous cell cancer, according to a recent population-based, cross-sectional study. “This is the first study to examine the association between atopic dermatitis and actinic keratosis [AK].... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 8, 2016 Category: Dermatology Source Type: news

Vitamin Prevents Skin Cancer: Only in Australia?Vitamin Prevents Skin Cancer: Only in Australia?
A phase 3 trial indicates that daily vitamin B3 prevents nonmelanoma skin cancer in high-risk patients. But experts wonder if it applies to other lands with different people. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Carcinoma: Basal Cell and Squamous Cell Carcinoma
Learn about the signs and symptoms of two forms of non-melanoma skin cancer and how they are diagnosed and treated. Also find out the best ways to prevent carcinoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 22, 2015 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: WebMD Health)
Source: WebMD Health - October 22, 2015 Category: Consumer Health News Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - October 22, 2015 Category: Cancer & Oncology Source Type: news

Vitamin B3 Tied to Lower Risk for Nonmelanoma Skin Cancer (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM Nicotinamide, a form of vitamin B3, is associated with reduced risk for developing nonmelanoma skin cancer among … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 22, 2015 Category: Primary Care Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 21, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Dermatology, Oncology, Nutrition, News, Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions Source: HealthDay Related MedlinePlus Pages: B Vitamins, Skin Cancer, Sun Exposure (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 21, 2015 Category: Consumer Health News Source Type: news

Concerns Over Sudden Increase in Radiation for Skin CancerConcerns Over Sudden Increase in Radiation for Skin Cancer
The use of first-line electronic brachytherapy for nonmelanoma skin cancer has risen 20-fold, raising concerns over inappropriate use. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Vitamin B3 derivative cuts risk of new skin cancers
(University of Sydney) A year of treatment with nicotinamide, a form of vitamin B3, significantly lowered the risk of common, non-melanoma skin cancer in high-risk patients, according to University of Sydney research published today in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 21, 2015 Category: Cancer & Oncology Source Type: news

Nonmelanoma skin cancer initially misdiagnosed in 36% of small cohort
In a small sample study, 10 (36%) of 28 children and young adults diagnosed with nonmelanoma skin cancer were given a misdiagnosis initially, suggesting that young patients with NMSC risk factors may require heightened monitoring from health care providers, according to a study published in Journal... (Source: Skin and Allergy News)
Source: Skin and Allergy News - October 20, 2015 Category: Dermatology Source Type: news

BRAF May Be a Good 'Target' in Nonmelanoma CancersBRAF May Be a Good 'Target' in Nonmelanoma Cancers
Early findings from a 'basket study' suggest that BRAF V600 may be a targetable oncogene in malignancies other than melanoma. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 19, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Overexposed: the sun damage that can lead to skin cancer – and how to treat it
Despite the warnings, many of us still overdo it in the summer sun. Here are the main types of skin damage to watch for and what to do about themSummer holidays still mean one thing for many people; basting in the sun until their skin tingles. But though it may top up vitamin D levels, too much sun is undoubtedly a bad thing, especially if you have light skin. One in five of us will get skin cancer at some stage, and there are more cases of skin cancer than all the other cancers put together. Consultant dermatologist Howard Stevens of Skin Care Network says the key messages are simple; avoid the sun between 11am and 3pm, c...
Source: Guardian Unlimited Science - August 16, 2015 Category: Science Authors: Ann Robinson Tags: Health & wellbeing Skin cancer Life and style Society Medical research Science Source Type: news

Non-Melanoma Skin Cancers Seen as Risk in AAV Patients (CME/CE)
(MedPage Today) -- But other malignancies seem no more common than in general population (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - August 12, 2015 Category: Consumer Health News Source Type: news

Non-Melanoma Skin Cancers Seen as Risk in AAV Patients (CME/CE)
(MedPage Today) -- But other malignancies seem no more common than in general population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 12, 2015 Category: Hematology Source Type: news

Advanced Dermatology and Cosmetic Surgery (ADCS Clinics) Partners with...
Advanced Dermatology and Cosmetic Surgery, the nation’s largest dermatology practice, partners with medical device company to help treat non-melanoma skin cancers and keloids(PRWeb August 07, 2015)Read the full story at http://www.prweb.com/releases/2015/08/prweb12890618.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 7, 2015 Category: Pharmaceuticals Source Type: news

New 'iClusters' identify five subtypes of prostate cancer
Conclusion Using DNA analysis, this study identified five subgroups (iClusters) of prostate cancer. A large portion of the iCluster-discriminating genes were not previously known to be linked to prostate cancer – an interesting finding in itself. The hope is the iClusters might help doctors treat the disease better based on their specific genetic signature. However, this study focused on developing reliable subgroups. It did not look at whether the groups improved treatment, disease progression or death rates from prostate cancer. This research is yet to be carried out. One of the main limitations of the r...
Source: NHS News Feed - July 31, 2015 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news

ACOS Holds First Meeting on Best Practices in Superficial Radiation Therapy for Non-Melanoma Skin Cancers
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - June 10, 2015 Category: Pharmaceuticals Source Type: news

Quarter of sun-exposed skin samples had DNA mutations
Conclusion This study estimated around 25% of normal skin cells have DNA mutations that could prime them to develop into skin cancer in the future. This was a lot higher than the scientists expected. The genetic analysis of the study was robust, but used skin samples from just four people. This severely limits the generalisablity of the findings to the general population. For example, the results might be different for people of different ages, sun exposures and skin colours, so we don't know if this is true for most people. Similarly, the researchers only used eyelid cells. There may be something unique about eyelid tiss...
Source: NHS News Feed - May 22, 2015 Category: Consumer Health News Tags: Cancer Lifestyle/exercise Source Type: news

ASCO: Vitamin B3 Derivative Cuts Risk for New Skin Cancers
(MedPage Today) -- Nicotainamide reduces nonmelanoma lesions by a fourth in high-risk patients. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 17, 2015 Category: Primary Care Source Type: news

Vitamin B3 may lower risk of skin cancer
Stephen FellerSYDNEY, May 15 (UPI) -- A form of vitamin B3 has been found to reduce the risk of non-melanoma skin cancers when taken regularly. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 15, 2015 Category: Consumer Health News Source Type: news

Vitamin B3 Helps Prevent Non-Melanoma Skin Cancers in High-Risk Adults
By Amy Orciari Herman Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Nicotinamide (a form of vitamin B3) reduces the incidence of non-melanoma skin cancers (NMSCs) in high-risk adults, according to study … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 15, 2015 Category: Primary Care Source Type: news

Nicotinamide cuts rate of nonmelanoma skin cancer in those at high risk
Nicotinamide, an inexpensive, over-the-counter form of vitamin B3, is safe and efficacious for the chemoprevention of nonmelanoma skin cancer in patients at high risk, according to data from the Australian Oral Nicotinamide to Reduce Actinic Cancer (ONTRAC) Study.
Source: Skin and Allergy News - May 14, 2015 Category: Dermatology Tags: SAN Conference News IMN Conferences FPN Conferences ONCR News ONCR Melanoma & Skin Cancers ONCR Prevention Epidemiology SAN Clinical News SAN News SAN SCN: Actinic Keratosis Source Type: news

B Vitamin Is Found to Help People Prone to Some Types of Skin Cancer
In a clinical trial involving 386 people, participants who received a form of vitamin B3 had a lower risk of getting non-melanoma skin cancer than those who received a placebo. (Source: NYT Health)
Source: NYT Health - May 14, 2015 Category: Consumer Health News Authors: ANDREW POLLACK Tags: Skin Cancer Diona Damian Clinical Trials American Society of Clinical Oncology Melanomas Vitamins Australia Source Type: news

New cancer treatment and prevention studies signal major advances for children and adults
(American Society of Clinical Oncology) The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 13, 2015 Category: Cancer & Oncology Source Type: news

Global Non-melanoma Skin Cancer Market Will Grow at 27% CAGR to 2018...
Global Non-melanoma Skin Cancer Market 2014-2018 is a market research report at RnRMarketResearch.com that profiles key players in the Global Non-melanoma Skin Cancer Market like Elekta AB, F....(PRWeb May 07, 2015)Read the full story at http://www.prweb.com/releases/non-melanoma-skin-cancer/market-global-2018/prweb12708173.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 8, 2015 Category: Pharmaceuticals Source Type: news

VIDEO: Updating the immune response to nonmelanoma skin cancer
ASHEVILLE, N.C. – Recent advances in basic science have shown how the local immune environment in tissue surrounding nonmelanoma skin cancer compares to adjacent normal tissue. New Mexico Health Sciences Center’s Dr. Andrew Ondo reviewed the latest research in
Source: Skin and Allergy News - May 1, 2015 Category: Dermatology Tags: SAN Video Library SAN Conference News SAN Clinical News SAN News SAN Actinic Keratosis SAN SCN: Squamous Cell Carcinoma ONCR News ONCR Video Library Source Type: news

VIDEO: Sun protection urged for Asian, Hispanic women
SAN FRANCISCO – Among Asian and Hispanic patients, women are more likely than men are to get nonmelanoma skin cancer, according to a review of 4,029 cases at the University of California, San Diego. That’s a... (Source: Skin and Allergy News)
Source: Skin and Allergy News - March 25, 2015 Category: Dermatology Tags: SAN Video Library ONCR Video OBGYN Video Library FPN Video Library IMN Video Library SAN Conference News Source Type: news

UT-Austin gets $900,000 for cancer research in latest CPRIT grants
The University of Texas in Austin fetched just $900,000 in funds for research out of $111.4 million in awards announced Wednesday by the Cancer Prevention and Research Institute of Texas. The 54 grants comprised four product development grants totaling $48.5 million and 51 grants for academic cancer research totaling $62.9 million. The grant for UT-Austin was given for a project researching treatments for non-melanoma skin cancer. In November researchers at UT-Austin received $4.9 million from CPRIT… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 18, 2015 Category: Biotechnology Authors: Chad Swiatecki Source Type: news

The Cancer That's Poised To Explode
Not long ago, a new medical epidemic arose: "the cancer." When people started to live longer, their aging bodies began to succumb to this disease we only poorly understood. Looking back, it is clear that much has changed for the better. As we recognize World Cancer Day 2015, we have a lot to celebrate. By a number of measures, we are on our way to beating cancer. The Susan G. Komen foundation is arguably the most powerful medical advocacy organization the world has ever seen, and the growing awareness of lung cancer has nearly suffocated the multi-billion dollar tobacco industry. In almost all corners of the wo...
Source: Healthy Living - The Huffington Post - February 13, 2015 Category: Consumer Health News Source Type: news

Coffee May Protect Against Some Skin Cancers
By: Stephanie Pappas Published: 01/20/2015 04:31 PM EST on LiveScience Go ahead, enjoy that morning mug. A new study suggests that people who are in the habit of drinking coffee regularly may be protected against malignant melanoma, the leading cause of skin-cancer death in the United States. People in the study who drank four or more cups of coffee daily were 20 percent less likely to develop malignant melanoma than noncoffee drinkers, according to the study published today (Jan. 20) in JNCI: Journal of the National Cancer Institute. Of course, the findings don't give you license to fire up the Mr. Coffee and then spen...
Source: Healthy Living - The Huffington Post - January 20, 2015 Category: Consumer Health News Source Type: news

Coffee may be associated with a lower risk of malignant melanoma
(Oxford University Press USA) Both epidemiological and pre-clinical studies have suggested that coffee consumption has a protective effect against non-melanoma skin cancers. However the protective effect for cutaneous melanoma (malignant and in situ) is less clear, according to a study published Jan. 20 in the JNCI: Journal of the National Cancer Institute. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 20, 2015 Category: Cancer & Oncology Source Type: news

Hydrochlorothiazide Tied to Non - Melanoma Skin Cancer Risk
Dose - response association seen for basal cell and especially squamous cell carcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 11, 2014 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Family Medicine, Internal Medicine, Oncology, Pathology, Pharmacy, Journal, Source Type: news

Painful, Itchy Patches Could Be Sign of Skin Cancer
But it's likely to be the non-melanoma type, dermatologist says (Source: WebMD Health)
Source: WebMD Health - July 23, 2014 Category: Consumer Health News Source Type: news